Y

Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675

Watchlist Manager
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Watchlist
Price: 12.32 CNY -1.91% Market Closed
Market Cap: 10.2B CNY
Have any thoughts about
Yantai Dongcheng Biochemicals Co Ltd?
Write Note

Yantai Dongcheng Biochemicals Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yantai Dongcheng Biochemicals Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Net Change in Cash
ÂĄ87.4m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Change in Cash
-ÂĄ5.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Change in Cash
ÂĄ381.7m
CAGR 3-Years
-37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Change in Cash
-ÂĄ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Change in Cash
ÂĄ362.5m
CAGR 3-Years
-50%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Net Change in Cash
-ÂĄ705.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Yantai Dongcheng Biochemicals Co Ltd
Glance View

Market Cap
10.2B CNY
Industry
Biotechnology

In the bustling industrial city of Yantai, nestled along China's northeastern coast, Yantai Dongcheng Biochemicals Co Ltd has emerged as a formidable entity in the global biopharmaceutical landscape. Founded in 1998, the company has cleverly positioned itself at the confluence of modern science and traditional Chinese medicine. The hallmark of Dongcheng's business is its sophisticated production of active pharmaceutical ingredients (APIs), particularly heparin, which has earned it a prominent spot on the world stage. Through its agile manufacturing processes and commitment to quality, the company deftly navigates the intricate web of pharmaceutical demands, supplying essential components to global drug manufacturers who trust Dongcheng's expertise to ensure efficacy and safety in their final products. The financial engine of Yantai Dongcheng Biochemicals is powered by its vertically integrated model, which extends from raw material acquisition to finished product delivery. This strategic structure not only mitigates costs and enhances supply chain stability but also fortifies its competitive edge in the burgeoning healthcare market. The company has also expanded its portfolio to include a diverse array of biochemical products, catering to various therapeutic areas such as anticoagulation, oncology, and anti-infectives. This diversification not only spreads risk but also captures a broader spectrum of revenue opportunities. Moreover, Dongcheng's keen eye for innovation has seen it invest heavily in research and development, ensuring that it remains at the cutting edge of biopharmaceutical advancements. Through this strategic orchestration of resources and innovation, Dongcheng continues to deepen its footprint in the global market, underscoring its reputation as a trusted and dynamic player in the pharmaceutical industry.

Intrinsic Value
18.38 CNY
Undervaluation 33%
Intrinsic Value
Price
Y

See Also

What is Yantai Dongcheng Biochemicals Co Ltd's Net Change in Cash?
Net Change in Cash
87.4m CNY

Based on the financial report for Sep 30, 2024, Yantai Dongcheng Biochemicals Co Ltd's Net Change in Cash amounts to 87.4m CNY.

What is Yantai Dongcheng Biochemicals Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
3%

The average annual Net Change in Cash growth rates for Yantai Dongcheng Biochemicals Co Ltd have been 3% over the past three years .

Back to Top